Annual report
7317.TEDINET S100TM9Z
Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 153
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥7.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥5.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥612m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥675m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥409m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥831m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥381m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥671m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥953m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥426m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥165m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥569m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥223m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥953m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥426m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥9.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥8.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥6.9bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥6.2bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥5.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.2bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥739m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥528m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥915m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥140m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥656m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥220m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥616m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥485m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥62m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥42m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥183m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥504m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥43m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥36m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥45.03 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.17 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.85 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.46 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.39 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥44.43 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥20.02 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥7.75 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.87 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥244.72 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥178.69 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥153.44 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥134.71 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥111.25 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 52.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.0% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 21.3% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.5% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 23.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,367 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 1,383 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,442 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 1,422 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,370 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥3.2bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥2.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥33m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥139m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥347m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥68m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥31m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥673m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥78m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥253m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥261m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥206m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥320m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | −¥4m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥469m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥20m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥4.1bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥567m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥454m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥913m | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥9.74 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-15.16 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.2 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.67 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.13 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.61 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.19 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥2.5 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥56.75 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥47.4 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥63.58 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥63.9 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥31.51 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 28.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.8% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 18.7% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -27.3% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -0.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 49.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 21,223,200 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,281,800 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,275,400 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,598,500 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,250,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 44 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 39 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 39 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 34 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 33 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2024-03-31 | ¥44m |
| Otherother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥44m |
| Otherother segments | segment assets | at 2024-03-31 | ¥23m |
| Otherother segments | segment profit | 2023-04-01 → 2024-03-31 | ¥19m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥4m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥944m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥295m |
| Medical Healthcarereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥297m |
| Medical Healthcarereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥116m |
| Medical Healthcarereportable segment | employees | at 2024-03-31 | 531 pure |
| Medical Healthcarereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Medical Healthcarereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Medical Healthcarereportable segment | segment assets | at 2024-03-31 | ¥3.9bn |
| Medical Healthcarereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Safety Systemreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥371m |
| Safety Systemreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥155m |
| Safety Systemreportable segment | employees | at 2024-03-31 | 827 pure |
| Safety Systemreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥3.0bn |
| Safety Systemreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥3.0bn |
| Safety Systemreportable segment | segment assets | at 2024-03-31 | ¥5.0bn |
| Safety Systemreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥167m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥668m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥271m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| Otherother segments | revenue | 2022-04-01 → 2023-03-31 | ¥24m |
| Otherother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥24m |
| Otherother segments | segment assets | at 2023-03-31 | ¥11m |
| Otherother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥2m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥533,000 |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥4m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥262m |
| Medical Healthcarereportable segment | capex | 2022-04-01 → 2023-03-31 | ¥711m |
| Medical Healthcarereportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥71m |
| Medical Healthcarereportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Medical Healthcarereportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Medical Healthcarereportable segment | segment assets | at 2023-03-31 | ¥3.4bn |
| Medical Healthcarereportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Safety Systemreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.2bn |
| Safety Systemreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥194m |
| Safety Systemreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Safety Systemreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Safety Systemreportable segment | segment assets | at 2023-03-31 | ¥4.2bn |
| Safety Systemreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥349m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥265m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥7.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥7.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥874m |
| Medical Healthcarereportable segment | employees | at 2024-03-31 | 18 pure |
| Safety Systemreportable segment | employees | at 2024-03-31 | 17 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,409
| Item | Context | Value | Unit |
|---|---|---|---|
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E35560-000HayashiNorieMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000HayashiNorieMember | Original text (Japanese)（注）３ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000NishikimiMitsuhiroMember | Original text (Japanese)監査役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000NishikimiMitsuhiroMember | Original text (Japanese)錦見 光弘 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000NishikimiMitsuhiroMember | 1963-05-13 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E35560-000NishikimiMitsuhiroMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000NishikimiMitsuhiroMember | Original text (Japanese)（注）３ | |
| Official title or position information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000UrushimaKeigoMember | Original text (Japanese)監査役 | |
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000UrushimaKeigoMember | Original text (Japanese)漆間 圭吾 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000UrushimaKeigoMember | 1987-09-08 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E35560-000UrushimaKeigoMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E35560-000UrushimaKeigoMember | Original text (Japanese)（注）３ | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding accumulated depreciation of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding provision for loss on order received included in cost of sales (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |